| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/19/2001 | US6248716 Prophylaxis or treatment of physical or mental stress-related disorders in an animal by administering an effective oligopeptide including tyrosine and phenylalanine units |
| 06/19/2001 | US6248715 Administering non-fucosylated polypeptide for treatment of metastasis, inflammation, rheumatoid arthritis, eye diseases |
| 06/19/2001 | US6248714 Methods of inhibiting binding and treating Ig-mediated responses with IL-13 receptor |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248712 Urokinase-type plasminogen activator receptor |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248587 Contacting cells with angiotensin/angiotensinogen derivative of specific amino acid sequence |
| 06/19/2001 | US6248586 Antisense modulation of PKA catalytic subunit C-alpha expression |
| 06/19/2001 | US6248576 Histidinol dehydrogenase |
| 06/19/2001 | US6248563 Chlamydia trachomatis serotype D genes |
| 06/19/2001 | US6248561 UCP3 genes |
| 06/19/2001 | US6248560 Nucleic acid encoding the analog which has at least one cysteine substituted with another amino acid to enhance formation of heterodimers; enhanced biological activity; treatment of gastrointestinal and hematopoietic disorders |
| 06/19/2001 | US6248558 Sequence and method for genetic engineering of proteins with cell membrane translocating activity |
| 06/19/2001 | US6248557 RatC |
| 06/19/2001 | US6248556 Nucleotide sequence of guanosine triphosphate-binding protein from staphylococcus; diagnosis of infections; drug screening; bactericides; bacteriostats; vaccines; probes; primers; vectors; host cells |
| 06/19/2001 | US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors |
| 06/19/2001 | US6248554 DNA sequence coding for a BMP receptor |
| 06/19/2001 | US6248551 Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides |
| 06/19/2001 | US6248548 Thrombosis prophylaxis for factor Vleiden carriers |
| 06/19/2001 | US6248538 Kit for detecting antibodies against preferential bacteria; for the detection of lyme disease |
| 06/19/2001 | US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators |
| 06/19/2001 | US6248527 Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E |
| 06/19/2001 | US6248520 Nucleic acid molecules encoding nuclear hormone receptor coactivators and uses thereof |
| 06/19/2001 | US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines |
| 06/19/2001 | US6248516 Library for expression of immunoglobulin heavy chain variable domains |
| 06/19/2001 | US6248375 Food bar |
| 06/19/2001 | US6248365 Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248360 Complexes to improve oral absorption of poorly absorbable antibiotics |
| 06/19/2001 | US6248351 Prevent transforming phenotype |
| 06/19/2001 | US6248334 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/19/2001 | US6248326 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
| 06/19/2001 | US6248325 Glutathione s-transferase |
| 06/19/2001 | US6248324 Topical applying mixture of lysis enzyme and carrier |
| 06/19/2001 | US6248319 Blood disorders |
| 06/19/2001 | US6248306 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 06/19/2001 | CA2218616C Nitrosylated neuropeptides |
| 06/19/2001 | CA2172187C Method of incorporating drugs into a polymer component of stents |
| 06/19/2001 | CA2137349C Peptide lung surfactants and therapeutic combinations |
| 06/19/2001 | CA2040180C Enzymatic process for the determination of beta-lactam antibiotics |
| 06/19/2001 | CA2038577C Utilization and delivery of enzymes |
| 06/19/2001 | CA2022539C Albumin derivatives with therapeutic functions |
| 06/19/2001 | CA2021116C Topical compositions containing live yeast cell derivative and other topically active medicinal ingredients |
| 06/14/2001 | WO2001042506A1 T1 receptor-like ligand ii and uses thereof |
| 06/14/2001 | WO2001042499A1 Method of testing remedy or preventive for hyperlipemia |
| 06/14/2001 | WO2001042484A1 Il-6 like polynucleotide |
| 06/14/2001 | WO2001042472A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042470A1 Nucleic acid and protein expressed thereby and their involvement in stress |
| 06/14/2001 | WO2001042467A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/14/2001 | WO2001042466A2 Zvwf1: a member of the von willebrand factor type a domain superfamily |
| 06/14/2001 | WO2001042465A2 Chordin-like molecules and uses thereof |
| 06/14/2001 | WO2001042464A2 Human preoptic regulatory factor-2 and uses thereof |
| 06/14/2001 | WO2001042463A1 Improving stability of flint through o-linked glycosylation |
| 06/14/2001 | WO2001042462A2 Phospholipase a2 inhibitory peptides from python reticulatus |
| 06/14/2001 | WO2001042461A2 Apoptin-associating protein |
| 06/14/2001 | WO2001042460A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 06/14/2001 | WO2001042459A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 06/14/2001 | WO2001042457A2 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses |
| 06/14/2001 | WO2001042449A2 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | WO2001042443A1 Method for modifying genetic characteristics of an organism |
| 06/14/2001 | WO2001042438A2 Leukolysin/mmp25/mt6-mmp |
| 06/14/2001 | WO2001042437A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 06/14/2001 | WO2001042435A2 Novel human kinase proteins and polynucleotides encoding the same |
| 06/14/2001 | WO2001042431A2 Regulation of human mitochondrial deformylase |
| 06/14/2001 | WO2001042306A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042304A1 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
| 06/14/2001 | WO2001042300A1 Process for producing functional silk fibroin and utilization of the same |
| 06/14/2001 | WO2001042297A2 Clasp-3 transmembrane protein |
| 06/14/2001 | WO2001042296A2 Clasp-5 transmembrane protein |
| 06/14/2001 | WO2001042295A2 Clasp-7 transmembrane protein |
| 06/14/2001 | WO2001042291A2 Polynucleotides and polypeptides encoded thereby |
| 06/14/2001 | WO2001042290A2 Novel steroid-activated nuclear receptors and uses therefor |
| 06/14/2001 | WO2001042289A2 Tetraspan polypetides and polynucleotides encoding same |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042285A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 06/14/2001 | WO2001042284A2 Protein comprising ig-like domain 4 of a vegf receptor mediates receptor dimerization, but not activation |
| 06/14/2001 | WO2001042282A1 Depsipeptide and congeners thereof for use as immunosuppressants |
| 06/14/2001 | WO2001042281A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/14/2001 | WO2001042280A2 Short peptides from the b4 and b5 regions of protein kinases which selectively modulate protein activity |
| 06/14/2001 | WO2001042262A2 Antithrombotic compound |
| 06/14/2001 | WO2001042246A2 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 06/14/2001 | WO2001042225A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
| 06/14/2001 | WO2001042193A1 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/14/2001 | WO2001041813A2 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/14/2001 | WO2001041812A2 Amphiphilic polymers and polypeptide conjugates comprising same |
| 06/14/2001 | WO2001041810A2 Nucleic acid delivery system |
| 06/14/2001 | WO2001041805A1 Novel cdna 22360 associated with renal disease and other disease states |
| 06/14/2001 | WO2001041799A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001041796A1 Method of combating undesirable hyperplastic cell proliferation |
| 06/14/2001 | WO2001041795A1 An additive for an animal feed |
| 06/14/2001 | WO2001041794A2 Activated amylase |
| 06/14/2001 | WO2001041793A1 A stable aqua formulation of interferon, the preparation method and the uses thereof |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001041791A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 06/14/2001 | WO2001041790A1 Botulinum toxin for reducing catecholamine secretion |
| 06/14/2001 | WO2001041789A1 Rheumatism remedy containing tetrapeptide derivative as active ingredient |
| 06/14/2001 | WO2001041787A1 INDUCING CELLULAR IMMUNE RESPONSES TO HER2/neu USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |